Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:33 AM
Ignite Modification Date:
2025-12-25 @ 3:33 AM
NCT ID:
NCT05653505
Eligibility Criteria:
Inclusion Criteria:
1. Patient admitted from Jan. 1st 2023 to Jan. 1st 2025;
2. Age ≥ 18;
3. Intracranial atherosclerosis stenosis measured as ≥70% by digital subtraction angiography or by other noninvasive methods, such as transcranial doppler, computed tomography angiography, or magnetic resonance angiography;
4. A history of stroke/transient ischemic attack attributed to ICAS;
5. Verbal and written informed consent is provided at the time of admission by patients or their legally authorized representatives.
Exclusion Criteria:
1. Stenosis of other causes;
2. Prior ipsilateral stroke with residual deficits;
3. Uncontrolled hypertension (defined as systolic blood pressure ≥200 mm Hg despite medications at enrollment);
4. Peripheral vascular disease (especially subclavian arterial and upper limb artery stenosis or occlusion).
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05653505
Study Brief:
Protocol Section:
NCT05653505